Chronic musculoskeletal pain is a highly prevalent condition that is often associated with persistent pain, physical disability, and maladaptive psychosocial factors such as pain catastrophizing, fear of movement, and central sensitization. These factors can contribute to pain persistence and reduced quality of life, highlighting the need for multimodal, non-pharmacological interventions that address both physical and psychological dimensions of pain. The purpose of this study is to evaluate the effectiveness of an active coping program for patients with chronic musculoskeletal pain compared with usual care. The intervention is designed to promote active pain management strategies through education, movement-based exercises, and behavioral approaches aimed at improving pain coping, reducing disability, and addressing psychosocial contributors to chronic pain. This is a controlled interventional study in which adult patients with chronic musculoskeletal pain will be allocated to either an intervention group receiving the active coping program or a control group receiving usual care. Outcome measures will be assessed at baseline and after completion of the intervention. Primary and secondary outcomes include pain-related disability, pain catastrophizing, fear of movement, symptoms of central sensitization, and health-related quality of life, measured using validated questionnaires. The findings of this study are expected to provide evidence on the clinical effectiveness of an active coping approach in the management of chronic musculoskeletal pain and to support its implementation in routine clinical practice within primary care settings.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pain Catastrophizing Scale (PCS)
Timeframe: Baseline (Week 0) and post-intervention (Week 8)
Roland-Morris Disability Questionnaire (RMDQ)
Timeframe: Baseline (Week 0) and post-intervention (Week 8)
Tampa Scale for Kinesiophobia (TSK-11)
Timeframe: Baseline (Week 0) and post-intervention (Week 8)
Central Sensitization Inventory (CSI)
Timeframe: Baseline (Week 0) and post-intervention (Week 8)
36-Item Short Form Health Survey (SF-36)
Timeframe: Baseline (Week 0) and post-intervention (Week 8)